Healthcare provider profile · identity verified

Sean A Mcintosh

Family Practice · O FALLON, MO · NPI 1700997731

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	522	130
Amlodipine Besylate	Amlodipine Besylate	485	130
Atorvastatin Calcium	Atorvastatin Calcium	471	130
Lisinopril	Lisinopril	360	104
Alprazolam	Alprazolam	274	61
Pravastatin Sodium	Pravastatin Sodium	272	78
Losartan Potassium	Losartan Potassium	251	68
Rosuvastatin Calcium	Rosuvastatin Calcium	232	71
Omeprazole	Omeprazole	217	59
Metoprolol Succinate	Metoprolol Succinate	210	54
Escitalopram Oxalate	Escitalopram Oxalate	194	53
Pantoprazole Sodium	Pantoprazole Sodium	185	57
Glimepiride	Glimepiride	175	47
Metformin Hcl	Metformin Hcl	170	53
Furosemide	Furosemide	169	51
Metoprolol Tartrate	Metoprolol Tartrate	161	44
Simvastatin	Simvastatin	160	49
Hydrochlorothiazide	Hydrochlorothiazide	156	44
Zolpidem Tartrate	Zolpidem Tartrate	154	27
Famotidine	Famotidine	131	36
Eliquis	Apixaban	124	34
Tamsulosin Hcl	Tamsulosin Hcl	123	38
Arexvy	Rsvpref3 Antigen/As01e/Pf	118	117
Meloxicam	Meloxicam	99	31
Citalopram Hbr	Citalopram Hydrobromide	97	25
Duloxetine Hcl	Duloxetine Hcl	91	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	30
Clopidogrel	Clopidogrel Bisulfate	86	24
Atenolol	Atenolol	85	22
Sertraline Hcl	Sertraline Hcl	85	22
Gabapentin	Gabapentin	83	23
Tramadol Hcl	Tramadol Hcl	81	31
Trazodone Hcl	Trazodone Hcl	81	28
Montelukast Sodium	Montelukast Sodium	76	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	74	21
Potassium Chloride	Potassium Chloride	69	16
Cefdinir	Cefdinir	68	56
Ezetimibe	Ezetimibe	67	25
Allopurinol	Allopurinol	66	19
Metformin Hcl Er	Metformin Hcl	65	21
Venlafaxine Hcl Er	Venlafaxine Hcl	65	16
Albuterol Sulfate Hfa	Albuterol Sulfate	62	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	20
Carvedilol	Carvedilol	56	16
Bupropion Xl	Bupropion Hcl	53	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	53	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	suppressed
Cephalexin	Cephalexin	52	35
Ondansetron Odt	Ondansetron	51	21
Fluticasone Propionate	Fluticasone Propionate	50	21
Synthroid	Levothyroxine Sodium	50	12
Finasteride	Finasteride	49	14
Oxybutynin Chloride	Oxybutynin Chloride	48	17
Ozempic	Semaglutide	45	suppressed
Clonidine Hcl	Clonidine Hcl	44	14
Hydralazine Hcl	Hydralazine Hcl	44	11
Methocarbamol	Methocarbamol	44	22
Lorazepam	Lorazepam	38	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Diazepam	Diazepam	35	12
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Spironolactone	Spironolactone	34	12
Memantine Hcl	Memantine Hcl	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	15
Vitamin D2	Ergocalciferol (Vitamin D2)	32	11
Colesevelam Hcl	Colesevelam Hcl	31	suppressed
Prednisone	Prednisone	31	23
Jardiance	Empagliflozin	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Amoxicillin	Amoxicillin	28	28
Azithromycin	Azithromycin	28	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Methylprednisolone	Methylprednisolone	27	22
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Valacyclovir	Valacyclovir Hcl	26	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	22
Doxepin Hcl	Doxepin Hcl	25	suppressed
Clonazepam	Clonazepam	23	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	17
Lovastatin	Lovastatin	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Naproxen	Naproxen	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Ketoconazole	Ketoconazole	19	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Nystatin	Nystatin	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Torsemide	Torsemide	14	suppressed
Baclofen	Baclofen	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Glipizide	Glipizide	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error